Sign In  |  Register  |  About Walnut Creek Guide  |  Contact Us

Walnut Creek, CA
September 01, 2020 1:43pm
7-Day Forecast | Traffic

  • Search Hotels in Walnut Creek Guide

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about SNY

Recent news which mentions SNY

< Previous 1 2
...
20 21 22 23 24 25 26 27 Next >
Acceleron In Advanced $11B Buyout Talks: Bloomberg
Tickers AMGN BMY GILD MRK
Tags SNY News Health Care
From Benzinga
Sanofi, Regeneron, Share Competitive Libtayo Survival Data in 1L NSCLC
Tickers REGN SNY
Tags General Non/Small Cell Lung Cancer REGN
From Benzinga
Here's Why Moderna's Stock Could Crash Before the End of 2021
Tickers AZN GSK JNJ MRNA
Tags AZN NVAX Market News
From Motley Fool
5 COVID Vaccine Stocks With Late-Stage Candidates You'll Want to Watch
Tickers DVAX GSK INO NVAX
Tags GSK INO SNY
From Motley Fool
AbbVie's Pain Is Sanofi's and Regeneron's Gain
Tickers ABBV PFE REGN SNY
Tags PFE SNY REGN
From Motley Fool
The Week Ahead In Biotech (Sept. 12-18): Calliditas FDA Decision, Adcom Review For Pfizer/BioNTech COVID-19 Vaccine, Oncology Conference And IPOs
Tickers ALRN AZN BIIB BNTX
Tags News CHRS Top Stories
From Benzinga
These Promising Clinical Results Could Be Huge for Amgen Investors
Tickers ABBV AMGN AZN GSK
Tags Market News AZN GSK
From Motley Fool
Can Pfizer Beat Sanofi and Regeneron in the Eczema Market?
Tickers PFE REGN SNY
Tags SNY PFE REGN
From Motley Fool
3 Stocks to Watch in September
Tickers ABBV CRLBF GOOG GOOGL
Tags GOOG ABBV LLY
From Motley Fool
Could This Be Pfizer's Next Blockbuster Vaccine?
Tickers BMY BNTX GSK JNJ
Tags BNTX Market News BMY
From Motley Fool
EMA Gives Nod To Additional Sites For Pfizer - BioNTech COVID-19 Vaccine
Tickers BNTX PFE SNY
Tags FDA COVID/19 Vaccine General
From Benzinga
Could This Label Expansion Be a Blockbuster for AbbVie's Shareholders?
Tickers ABBV LLY PFE REGN
Tags Market News ABBV LLY
From Motley Fool
2 Top Healthcare Stocks That Could Boost Your Portfolio in September (and Beyond)
Tickers HCA LLY NVO SNY
Tags HCA SNY LLY
From Motley Fool
Sanofi's BTK Inhibitor Disappoints In Phase 3 Autoimmune Disease Trial
Tickers SNY
Tags Market News General Health Care
From Benzinga
The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi's Pemphigus Trial Disappointment, Humanigen's COVID-19 Drug Denied Emergency Use Authorization
Tickers ABSI ABT AZN BIVI
Tags DGX FDA IBB
From Benzinga
KDMN Stock: 6 Things to Know About Biopharma Kadmon Holdings as Shares Skyrocket
Tickers EFTR KDMN SNY
Tags Today's Market SNY KDMN
From InvestorPlace
Why Kadmon Holdings Stock Is Rocketing Higher Today
Tickers KDMN SNY TBIO
Tags Market News KDMN TBIO
From Motley Fool
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Tickers AEI ARQQ ATIF BBIG
Tags AEI BBIG PATH
From InvestorPlace
There’s an ETF sending one market haywire. A hedge-fund pro says bitcoin-like gains may come next.
Tickers BITCOMP CCJ COIN CTXS
Tags CTXS NIO SNY
From MarketWatch
Sanofi's $1.9 Billion Bet On Kadmon: What You Need to Know
Tickers KDMN SNY TBIO
Tags Benzinga KDMN Biotech
From Benzinga
U.S. stock futures point to losses for Wall Street as delta worries linger
Tickers COMP KDMN NIO SNY
Tags YM00 XX:SXXP DXY
From MarketWatch
3 Hot Stocks to Buy in September
Tickers DOCU MDB NTLA REGN
Tags REGN MDB SNY
From Motley Fool
Got $5,000? These 2 Dividend Stocks Are Dirt Cheap Buys
Tickers SNY SU VTRS
Tags SU VTRS SNY
From Motley Fool
3 Biotech Stocks That Are Too Cheap to Ignore
Tickers ABBV AXSM JAZZ REGN
Tags AXSM ABBV Market News
From Motley Fool
Attention Biotech Investors: Mark Your Calendar For September PDUFA Dates
Tickers ABBV ASND BGNE BIIB
Tags Benzinga Biotech IMPL
From Benzinga
4 Specialized AI Stocks to Buy for the Boom
Tickers BMY ICAD MARK PLTR
Tags PLTR MARK Market News
From InvestorPlace
Glaxo, SK Bioscience Start COVID-19 Vaccine Trial Against AstraZeneca Shot
Tickers AZN CVAC GSK SNY
Tags Phase 3 Trial Benzinga Biotech
From Benzinga
Pfizer's Abrocitinib Beats Dupixent Late-stage Eczema Trial
Tickers PFE REGN SNY
Tags General Benzinga Phase 3 Trial
From Benzinga
Dupixent Becomes First Biologic To Show Benefit In Infant Patients With Atopic Dermatitis
Tickers REGN SNY
Tags General Market News News
From Benzinga
Which Biotech Stock Will Shock the Market in 2022?
Tickers AXSM AZN NDAQ NVAX
Tags Market News SGEN NVAX
From Motley Fool
< Previous 1 2
...
20 21 22 23 24 25 26 27 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 WalnutCreekGuide.com & California Media Partners, LLC. All rights reserved.